Form 8-K - Current report:
SEC Accession No. 0001193125-24-244590
Filing Date
2024-10-28
Accepted
2024-10-28 07:00:28
Documents
13
Period of Report
2024-10-28
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d895225d8k.htm   iXBRL 8-K 29764
  Complete submission text file 0001193125-24-244590.txt   153988

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tyra-20241028.xsd EX-101.SCH 2831
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyra-20241028_lab.xml EX-101.LAB 17980
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyra-20241028_pre.xml EX-101.PRE 11246
15 EXTRACTED XBRL INSTANCE DOCUMENT d895225d8k_htm.xml XML 3629
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40800 | Film No.: 241398414
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)